Most American hospital patients are given drugs not approved by the U.S. Food and Drug Administration for the prescribed use. If off-label prescribing is so widespread and successful, is the FDA’s pre-approval process really necessary?
Assessing the FDA via the Anomaly of Off-Label Drug Prescribing
By Alexander T. Tabarrok
This
article
appeared in
the Summer 2000 issue of The Independent Review.
Download PDF
(29 pages)
| Other Independent Review articles by Alexander T. Tabarrok | ||
| Fall 2019 | Premature Imitation and India’s Flailing State | |
| Fall 2013 | The Global Organ Shortage: Economic Causes, Human Consequences, Policy Responses | |
| Spring 2007 | The Rise, Fall, and Rise Again of Privateers | |
| [View All (5)] | ||
